Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract

Purpose: The aim of this study was to evaluate the intraluminal behavior of various transporter substrates in different regions of the gastrointestinal (GI) tract. Methods: Drug solutions containing non-absorbable FITC-dextran 4000 (FD-4), were orally administered to rats. Residual water was sample...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yusuke Tanaka, Taiki Harada, Kazuhiro Ito, Takanori Kurakazu, Satoshi Kasaoka
Formato: article
Lenguaje:EN
Publicado: Canadian Society for Pharmaceutical Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/15a4c67c5ec84d24bbc2bf8772379dbf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:15a4c67c5ec84d24bbc2bf8772379dbf
record_format dspace
spelling oai:doaj.org-article:15a4c67c5ec84d24bbc2bf8772379dbf2021-12-02T18:38:02ZIntraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract10.18433/jpps323141482-1826https://doaj.org/article/15a4c67c5ec84d24bbc2bf8772379dbf2021-11-01T00:00:00Zhttps://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32314https://doaj.org/toc/1482-1826 Purpose: The aim of this study was to evaluate the intraluminal behavior of various transporter substrates in different regions of the gastrointestinal (GI) tract. Methods: Drug solutions containing non-absorbable FITC-dextran 4000 (FD-4), were orally administered to rats. Residual water was sampled from the GI regions to measure the luminal drug concentration. Results: Cephalexin (CEX), a substrate of the proton-coupled oligopeptide transporter, was absorbed rapidly, and no drug was detected in the lower small intestine. Saquinavir (SQV) was primarily absorbed in the upper region. However, unlike CEX, SQV was detected even in the lower segment probably due to the efflux of SQV via P-glycoprotein (P-gp). The concentration of methotrexate (MTX) showed a similar pattern to that of non-absorbable FD-4. The low absorption of MTX was probably due to efflux via several efflux transporters, and the limited expression of proton-coupled folate transporter, an absorptive transporter for MTX, in the upper region. Conclusion: This study revealed that the luminal concentration pattern of each drug differed considerably depending on the site because of the different absorption properties and luminal volumes. Although further investigation using a specific transporter inhibitor or transporter-knockout animals are necessary to clarify the actual contribution of each transporter to the drug absorption, this information will be valuable in evaluating transporter-mediated drug absorption in in vitro transport studies for ensuring optimal drug concentrations. Yusuke TanakaTaiki HaradaKazuhiro ItoTakanori KurakazuSatoshi KasaokaCanadian Society for Pharmaceutical SciencesarticleTherapeutics. PharmacologyRM1-950Pharmacy and materia medicaRS1-441ENJournal of Pharmacy & Pharmaceutical Sciences, Vol 24 (2021)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
spellingShingle Therapeutics. Pharmacology
RM1-950
Pharmacy and materia medica
RS1-441
Yusuke Tanaka
Taiki Harada
Kazuhiro Ito
Takanori Kurakazu
Satoshi Kasaoka
Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
description Purpose: The aim of this study was to evaluate the intraluminal behavior of various transporter substrates in different regions of the gastrointestinal (GI) tract. Methods: Drug solutions containing non-absorbable FITC-dextran 4000 (FD-4), were orally administered to rats. Residual water was sampled from the GI regions to measure the luminal drug concentration. Results: Cephalexin (CEX), a substrate of the proton-coupled oligopeptide transporter, was absorbed rapidly, and no drug was detected in the lower small intestine. Saquinavir (SQV) was primarily absorbed in the upper region. However, unlike CEX, SQV was detected even in the lower segment probably due to the efflux of SQV via P-glycoprotein (P-gp). The concentration of methotrexate (MTX) showed a similar pattern to that of non-absorbable FD-4. The low absorption of MTX was probably due to efflux via several efflux transporters, and the limited expression of proton-coupled folate transporter, an absorptive transporter for MTX, in the upper region. Conclusion: This study revealed that the luminal concentration pattern of each drug differed considerably depending on the site because of the different absorption properties and luminal volumes. Although further investigation using a specific transporter inhibitor or transporter-knockout animals are necessary to clarify the actual contribution of each transporter to the drug absorption, this information will be valuable in evaluating transporter-mediated drug absorption in in vitro transport studies for ensuring optimal drug concentrations.
format article
author Yusuke Tanaka
Taiki Harada
Kazuhiro Ito
Takanori Kurakazu
Satoshi Kasaoka
author_facet Yusuke Tanaka
Taiki Harada
Kazuhiro Ito
Takanori Kurakazu
Satoshi Kasaoka
author_sort Yusuke Tanaka
title Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
title_short Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
title_full Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
title_fullStr Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
title_full_unstemmed Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract
title_sort intraluminal behavior of various transporter substrates in the rat gastrointestinal tract
publisher Canadian Society for Pharmaceutical Sciences
publishDate 2021
url https://doaj.org/article/15a4c67c5ec84d24bbc2bf8772379dbf
work_keys_str_mv AT yusuketanaka intraluminalbehaviorofvarioustransportersubstratesintheratgastrointestinaltract
AT taikiharada intraluminalbehaviorofvarioustransportersubstratesintheratgastrointestinaltract
AT kazuhiroito intraluminalbehaviorofvarioustransportersubstratesintheratgastrointestinaltract
AT takanorikurakazu intraluminalbehaviorofvarioustransportersubstratesintheratgastrointestinaltract
AT satoshikasaoka intraluminalbehaviorofvarioustransportersubstratesintheratgastrointestinaltract
_version_ 1718377723957608448